Page 3 - Shenzhen Kangtai News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shenzhen kangtai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shenzhen Kangtai Today - Breaking & Trending Today

Lex Letter from Seoul: China's vaccines and efficacy rates


Home
Lex Letter from Seoul: China’s vaccines and efficacy rates
Lex Letter from Seoul: China’s vaccines and efficacy rates
Demand for Sinovac’s CoronaVac will remain high. In most developing countries, it is the only option
World Economy News
Dear readers,
Who will get immunised first or at all is a hot topic of conversation worldwide. Vaccine shortages add to the uncertainty. Covid-19 shot manufacturers such as Pfizer are hitting production limits. But in Asia, Chinese vaccine makers have no problem meeting demand.
State-owned Sinopharm and Sinovac have shipped more than 20m doses to developing countries including Turkey, Brazil, the Philippines and Thailand. The two businesses have signed deals to provide hundreds of millions of further doses. More than 15m shots have been administered in China, according to the National Health Commission. ....

Oxford Astrazeneca , June Yoonlex , Cansino Biologics , National Health Commission , National Health , Sino Biopharmaceutical , Shenzhen Kangtai , கேன்சினோ உயிரியல் , தேசிய ஆரோக்கியம் தரகு , தேசிய ஆரோக்கியம் , ஷென்சென் காங்க்டை ,

In China's Covid-19 vaccine race, five stocks are on analysts' watch list as clinical trials end, production anticipated


In China’s Covid-19 vaccine race, five stocks are on analysts’ watch list as clinical trials end, production anticipated
CanSino Biologics, Chongqing Zhifei and Shenzhen Kangtai are preparing to commercialise their Covid-19 vaccine candidates, pending trial results
Makers of ultra-low temperature freezers also stand to gain from demand for storage and transportation of vaccine doses ....

Co Vid , Corona Virus , Shenzhen Kangtai , Chongqing Zhifei , Fosun Pharma , இணை வித் , கொரோனா வைரஸ் , சர்வதேச பரவல் , ஷென்சென் காங்க்டை ,